AGA-(C8R) HNG17, Humanin derivative is a potent humanin (HN) derivative. AGA-(C8R) HNG17, Humanin derivative completely suppresses neuronal cell death by Alzheimer's disease-relevant insults.
AGA-(C8R) HNG17, Humanin derivative, is a synthetic peptide modeled after the naturally occurring neuroprotective peptide Humanin, with a specific amino acid substitution at position 8 (cysteine to arginine). As a member of the Humanin peptide family, AGA-(C8R) HNG17 is of significant interest in the study of cellular stress responses, mitochondrial function, and peptide-based modulation of intracellular signaling pathways. Its structural modification is designed to enhance certain biochemical properties, making it a valuable tool for researchers investigating the mechanistic basis of peptide activity and cellular resilience under various stress conditions.
Peptide Mechanism Studies: Researchers utilize AGA-(C8R) HNG17 in mechanistic studies to dissect the structure-activity relationships governing Humanin family peptides. The C8R substitution provides a unique opportunity to evaluate the impact of specific amino acid changes on peptide conformation, stability, and receptor interactions. By comparing the biological activity of this derivative to native Humanin, scientists can gain insights into the determinants of peptide efficacy and specificity, informing the rational design of next-generation bioactive peptides.
Mitochondrial Stress Research: The synthetic peptide serves as a model compound for exploring mitochondrial resilience and stress adaptation. Humanin derivatives, including AGA-(C8R) HNG17, are often incorporated into in vitro cellular models to probe mitochondrial signaling networks, assess peptide-mediated cytoprotection, and elucidate pathways involved in oxidative stress response. These studies contribute to a deeper understanding of mitochondrial homeostasis and the modulation of apoptosis-related signaling cascades.
Cellular Signaling Pathway Analysis: AGA-(C8R) HNG17 is employed to investigate the modulation of intracellular signaling pathways, particularly those implicated in cell survival and stress adaptation. Its application in cell-based assays allows for the assessment of downstream effects on key signaling molecules, such as STAT3 and ERK1/2, following peptide treatment. This research direction aids in clarifying the molecular mechanisms by which Humanin derivatives influence cellular fate decisions and stress tolerance.
Peptide Stability and Bioavailability Evaluation: The C8R modification in AGA-(C8R) HNG17 makes it a pertinent model for examining peptide stability, proteolytic resistance, and bioavailability in experimental systems. Researchers use the peptide to test hypotheses regarding the role of amino acid substitutions in enhancing peptide half-life and functional persistence in biological environments. Such studies are integral to the development of more robust peptide-based probes and reagents for laboratory research.
Peptide Synthesis and Analytical Method Development: The Humanin derivative is also valuable in the context of peptide synthesis optimization and analytical method development. Its defined sequence and physicochemical properties make it suitable as a reference standard or test substrate in chromatographic, spectrometric, and mass spectrometric analyses. These applications facilitate the refinement of peptide purification protocols, structural characterization techniques, and quality control measures in peptide chemistry laboratories.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More